RVL Pharmaceuticals plc Quarterly Unrecognized Tax Benefits in USD from Q4 2017 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
RVL Pharmaceuticals plc quarterly Unrecognized Tax Benefits history and growth rate from Q4 2017 to Q4 2022.
  • RVL Pharmaceuticals plc Unrecognized Tax Benefits for the quarter ending December 31, 2022 was $179K, a 2.29% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $179K +$4K +2.29% Dec 31, 2022 10-K 2023-03-20
Q4 2021 $175K +$4K +2.34% Dec 31, 2021 10-K 2023-03-20
Q4 2020 $171K -$2.51M -93.6% Dec 31, 2020 10-K 2023-03-20
Q4 2019 $2.68M +$459K +20.7% Dec 31, 2019 10-K 2022-03-30
Q4 2018 $2.22M +$571K +34.7% Dec 31, 2018 8-K 2021-09-08
Q4 2017 $1.65M Dec 31, 2017 10-K 2020-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.